Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Laboratory Corporation of America Holdings    LH

LABORATORY CORPORATION OF AMERICA HOLDINGS

(LH)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/27 03:10:30 pm
207.165 USD   +2.58%
07:55aLABORATORY OF AMERICA : Q3 2020 Earnings Press Release
PU
06:57aLABCORP : 3Q Earnings Snapshot
AQ
06:46aLABCORP : Announces 2020 Third Quarter Results
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
205.21(c) 203.16(c) 205.26(c) 207.49(c) 201.96(c) Last
918 033 652 199 609 980 677 391 788 600 Volume
+2.65% -1.00% +1.03% +1.09% -2.67% Change
More quotes
Financials (USD)
Sales 2020 12 789 M - -
Net income 2020 984 M - -
Net Debt 2020 4 576 M - -
P/E ratio 2020 20,1x
Yield 2020 -
Sales 2021 13 139 M - -
Net income 2021 1 139 M - -
Net Debt 2021 4 061 M - -
P/E ratio 2021 17,2x
Yield 2021 -
Capitalization 19 671 M 19 671 M -
EV / Sales 2020 1,90x
EV / Sales 2021 1,81x
Nbr of Employees 65 000
Free-Float 99,4%
More Financials
Company
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - supply of testing services (59.5%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - supply of genomic and esoteric testing services (40.5%). Net sales are distributed geographically as follows : the... 
More about the company
Notations Surperformance© of Laboratory Corporation of America Holdings
Trading Rating : Investor Rating :
More Ratings
All news about LABORATORY CORPORATION OF AMERICA HOLDINGS
07:55aLABORATORY OF AMERICA : Q3 2020 Earnings Press Release
PU
06:57aLABCORP : 3Q Earnings Snapshot
AQ
06:46aLABCORP : Announces 2020 Third Quarter Results
BU
05:13aLABORATORY OF AMERICA : Global Drug Screening Laboratory Services Market to Gain..
AQ
10/22LABORATORY CORPORATION OF AMERICA HO : quaterly earnings release
10/21LABORATORY OF AMERICA : LabCorp Transforms the Clinical Trial Experience and Str..
AQ
10/20LABORATORY OF AMERICA : LabCorp Launches Quantitative Antibody Test to Assess Ef..
AQ
10/20LABORATORY OF AMERICA : LabCorp and Swedish Extend Laboratory Services Relations..
AQ
10/20LABCORP : Transforms the Clinical Trial Experience And Streamlines the Drug Deve..
BU
10/19LABCORP : and Swedish Extend Laboratory Services Relationship, Providing Continu..
BU
10/19LABORATORY OF AMERICA : Thinking about trading options or stock in Niu Technolog..
PR
10/19LABCORP : Launches Quantitative Antibody Test to Assess Effectiveness of COVID-1..
BU
10/14LABORATORY OF AMERICA : LabCorp Is First to Provide Consumers with Secure Access..
AQ
10/13LABCORP : Is First to Provide Consumers With Secure Access to Their Diagnostic T..
BU
10/12LABORATORY OF AMERICA : LabCorp and HealthEC Launch Transformative Oncology Care..
AQ
More news
News in other languages on LABORATORY CORPORATION OF AMERICA HOLDINGS
10/22LABORATORY CORPORATION OF AMERICA HO : Veröffentlichung des Quartalsergebnisses
10/22LABORATORY CORPORATION OF AMERICA HO : publication des résultats trimestriels
09/28GENFIT : signe un contrat exclusif de licence avec LabCorp pour un test de la NA..
07/23LABORATORY CORPORATION OF AMERICA HO : Veröffentlichung des Halbjahresergebnisse..
07/23LABORATORY CORPORATION OF AMERICA HO : publication des résultats semestriels
More news
Stock Trading Strategies
LABORATORY CORPORATION OF AMERICA HOLDINGS - 10/23
Close to a key resistance level
BUY
More Stock Trading Analysis
Chart LABORATORY CORPORATION OF AMERICA HOLDINGS
Duration : Period :
Laboratory Corporation of America Holdings Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LABORATORY CORPORATION OF AMERICA HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 230,36 $
Last Close Price 201,96 $
Spread / Highest target 23,3%
Spread / Average Target 14,1%
Spread / Lowest Target 3,49%
EPS Revisions
Managers
NameTitle
Adam H. Schechter President, Chief Executive Officer & Director
David P. King Chairman
Glenn Andrew Eisenberg Chief Financial Officer, Treasurer & Executive VP
Lance V. Berberian Chief Information Officer & Senior Vice President
Brian J. Caveney Chief Medical Officer, EVP & President-Diagnostics